Loading…
Sandu Pharmaceuticals (BSE 524703)₹36.72−0.62%Pharmaceuticals
Sandu Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 19.7 against a peer median of 15.3, and ROCE of 6.5% against a peer median of 6.5%, and latest-quarter sales growth of 19.9% against a peer median of 2.4%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vasundhara Rasayans | 44 | 7.4 | 20.2 | 15.2 | 0.04 | 1.5 | 36 | 6 | 53.1 | 441.3 | vs BSE 524703 |
| Chandra Bhagat Pharma | 43 | 14.3 | 12.1 | 9.6 | 0.50 | 0.0 | 116 | 3 | 313.6 | — | vs BSE 524703 |
| Kabra Drugs | 42 | 8.4 | 20.8 | 18.3 | 0.02 | 0.0 | 93 | 5 | — | 167.5 | vs BSE 524703 |
| Vista Pharmaceuticals | 41 | — | −30.0 | −29.5 | 0.27 | 0.0 | 5 | −12 | −100.0 | — | vs BSE 524703 |
| Bharat Immunological & Biological Corporation | 38 | — | −8.9 | −17.7 | 0.94 | 0.0 | 45 | −17 | −100.0 | — | vs BSE 524703 |
| Rajnish Wellness | 38 | — | −9.0 | −6.7 | 0.00 | 0.0 | 143 | −6 | 1,667.0 | — | vs BSE 524703 |
| Sandu Pharmaceuticals | 36 | 19.7 | 6.5 | 4.1 | 0.01 | 2.2 | 70 | 2 | 19.9 | −90.6 | — |
| Gujarat Terce Laboratories | 35 | 16.4 | 39.3 | 30.2 | 0.13 | 0.0 | 47 | 2 | −17.1 | — | vs BSE 524703 |
| Roopa Industries | 35 | 549.5 | 15.0 | 23.2 | 1.75 | 0.0 | 128 | 0 | 1.0 | −434.9 | vs BSE 524703 |
| Medi Caps | 32 | — | −2.6 | −2.6 | 0.00 | 0.0 | 12 | −3 | 3.7 | — | vs BSE 524703 |
| Medicamen Organics | 32 | — | −10.6 | −13.8 | 0.50 | 0.0 | 23 | −4 | −77.9 | −338.4 | vs BSE 524703 |
| Peer median | 38 | 15.3 | 6.5 | 4.1 | 0.13 | 0.0 | 47 | 0 | 2.4 | −90.6 |
Listed companies closest to Sandu Pharmaceuticals in Pharmaceuticals include Vasundhara Rasayans, Chandra Bhagat Pharma, Kabra Drugs, Vista Pharmaceuticals, Bharat Immunological & Biological Corporation, Rajnish Wellness, Gujarat Terce Laboratories, Roopa Industries.
Vasundhara Rasayans, with a market cap of ₹43.71 Cr.
Sandu Pharmaceuticals trades at a P/E of 19.7; the median of its peer set is 15.3. A P/E above or below the median is a description, not a judgement on value.
Sandu Pharmaceuticals' return on capital employed is 6.5%, above the peer median of 6.5%.